Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-02-29

Clinical Trial Update: Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters [NA]

View source ↗

Summary

This clinical trial update reports on the effects of glucagon-like peptide-1 on haemodynamic parameters in heart failure; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • glucagon-like peptide-1 (glucagon-like peptide-1)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Heart Failure | NA | Status: UNKNOWN